Orchestra BioMed Hldgs Stock (NASDAQ: OBIO) stock price, news, charts, stock research, profile.
Open | $8.17 |
Close | $7.52 |
Volume / Avg. | 129.32K / 128.76K |
Day Range | 7.08 - 8.17 |
52 Wk Range | 4.22 - 11.69 |
Market Cap | $307.78M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 5.31% |
Days to Cover | 3.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Orchestra BioMed Hldgs (NASDAQ:OBIO) through any online brokerage.
Other companies in Orchestra BioMed Hldgs’s space includes: Axogen (NASDAQ:AXGN), NeuroPace (NASDAQ:NPCE), Semler Scientific (NASDAQ:SMLR), Sight Sciences (NASDAQ:SGHT) and AngioDynamics (NASDAQ:ANGO).
There is no analysis for Orchestra BioMed Hldgs.
Orchestra BioMed Hldgs has a consensus price target of $16.00.
The stock price for Orchestra BioMed Hldgs (NASDAQ: OBIO) is $8.6 last updated July 26, 2024 at 7:41 AM EDT.
There are no upcoming dividends for Orchestra BioMed Hldgs.
Orchestra BioMed Hldgs’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Orchestra BioMed Hldgs.
Orchestra BioMed Hldgs is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.